More articles from Articles

You have accessRestricted Access
Impact of Target Organ Damage Assessment in the Evaluation of Global Risk in Patients with Essential Hypertension
Francesca Viazzi, Giovanna Leoncini, Denise Parodi, Elena Ratto, Simone Vettoretti, Valentina Vaccaro, Angelica Parodi, Valeria Falqui, Cinzia Tomolillo, Giacomo Deferrari and Roberto Pontremoli

JASN March 2005, 16 (3 suppl 1) S89-S91; DOI: https://doi.org/10.1681/ASN.2004110956

Add to Selected Citations
You have accessRestricted Access
Prevention and Treatment of Diabetic Nephropathy: The Program for Irbesartan Mortality and Morbidity Evaluation
Maura Ravera, Elena Ratto, Simone Vettoretti, Denise Parodi and Giacomo Deferrari

JASN March 2005, 16 (3 suppl 1) S48-S52; DOI: https://doi.org/10.1681/ASN.2004110957

Add to Selected Citations
You have accessRestricted Access
Individual Titration for Maximal Blockade of the Renin-Angiotensin System in Proteinuric Patients: A Feasible Strategy?
Liffert Vogt, Gerjan Navis and Dick de Zeeuw

JASN March 2005, 16 (3 suppl 1) S53-S57; DOI: https://doi.org/10.1681/ASN.2004121074

Add to Selected Citations
You have accessRestricted Access
Angiotensin-Converting Enzyme Inhibition and Renal Protection in Nondiabetic Patients: The Data of the Meta-Analyses
Carlos Chiurchiu, Giuseppe Remuzzi and Piero Ruggenenti

JASN March 2005, 16 (3 suppl 1) S58-S63; DOI: https://doi.org/10.1681/ASN.2004110968

Add to Selected Citations
You have accessRestricted Access
Calcium Channel Blockers and Renal Protection: Insights from the Latest Clinical Trials
Julián Segura, José A. García-Donaire and Luis M. Ruilope

JASN March 2005, 16 (3 suppl 1) S64-S66; DOI: https://doi.org/10.1681/ASN.2004110969

Add to Selected Citations
You have accessRestricted Access
Epoetin-Induced Autoimmune Pure Red Cell Aplasia
Nicole Casadevall, Kai-Uwe Eckardt and Jérôme Rossert

JASN March 2005, 16 (3 suppl 1) S67-S69; DOI: https://doi.org/10.1681/ASN.2004110959

Add to Selected Citations
You have accessRestricted Access
Should a Diuretic Always Be the First Choice in Patients with Essential Hypertension? The Case for No
Alberto Morganti

JASN March 2005, 16 (3 suppl 1) S70-S73; DOI: https://doi.org/10.1681/ASN.2004110964

Add to Selected Citations
You have accessRestricted Access
Joint National Committee VII and European Society of Hypertension/European Society of Cardiology Guidelines for Evaluating and Treating Hypertension: A Two-Way Road?
Giuseppe Mancia and Guido Grassi

JASN March 2005, 16 (3 suppl 1) S74-S77; DOI: https://doi.org/10.1681/ASN.2004110963

Add to Selected Citations
You have accessRestricted Access
Acute-Phase Markers of Inflammation and Glomerular Structure in Patients with Type 2 Diabetes
Michele Dalla Vestra, Michele Mussap, Pietro Gallina, Marino Bruseghin, Anna Maria Cernigoi, Alois Saller, Mario Plebani and Paola Fioretto

JASN March 2005, 16 (3 suppl 1) S78-S82; DOI: https://doi.org/10.1681/ASN.2004110961

Add to Selected Citations
You have accessRestricted Access
Inflammation Markers, Adhesion Molecules, and All-Cause and Cardiovascular Mortality in Patients with ESRD: Searching for the Best Risk Marker by Multivariate Modeling
Giovanni Tripepi, Francesca Mallamaci and Carmine Zoccali

JASN March 2005, 16 (3 suppl 1) S83-S88; DOI: https://doi.org/10.1681/ASN.2004110972

Add to Selected Citations

Main menu

User menu

Search

More articles from Articles

Pages

About

Author Information

More Information